Why track resting heart rate by week?
People often notice wearable changes after starting semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1. The hard part is separating a medication-timing pattern from normal noise: poor sleep, calorie restriction, dehydration, caffeine, illness, travel, exercise load, or a stressful week.
A clean timeline makes the question narrower. Instead of asking whether a GLP-1 caused a number, you can ask whether resting heart rate changes cluster around injection day, dose increases, missed-dose weeks, or low-recovery weeks.
Week-by-week timeline to build
| Week | What to compare | Context to tag |
|---|---|---|
| Baseline week | Your usual morning resting heart rate before the first shot or before a dose increase. | Sleep average, caffeine, exercise, illness, stress level, wearable source. |
| Week 1 | Whether resting heart rate changes on Day 0-3, Day 4-7, or across the entire first week. | Appetite drop, nausea, hydration, constipation, lower food intake, anxiety. |
| Weeks 2-4 | Whether the pattern settles, repeats after each injection, or drifts upward with cumulative recovery strain. | Sleep debt, workouts, alcohol, illness, travel, missed or late dose timing. |
| Dose increase weeks | Whether the increase creates a temporary shift compared with stable-dose weeks. | New dose, exact date/time, GI symptoms, hydration changes, under-eating risk. |
| Stable-dose months | Whether resting heart rate returns toward baseline, stays elevated, or varies mainly with sleep and stress. | Weight change pace, training load, stimulant sensitivity, ongoing symptoms. |
Daily fields that make the timeline useful
- Injection timestamp: date, time, dose, medication name, and whether the shot was on schedule.
- Resting heart rate: use the same wearable source when possible and look at multi-day trends.
- Sleep and recovery: duration, quality, HRV trend, and whether the night was unusual.
- Hydration and intake: low fluids, low calories, missed meals, nausea, reflux, constipation, or vomiting.
- Stimulants and stress: caffeine, decongestants, alcohol, heavy work stress, travel, or illness.
- Symptoms: palpitations, dizziness, shortness of breath, chest discomfort, anxiety, fatigue, or exercise intolerance.
Simple GLP-1 resting heart rate log template
| Day | Dose context | Resting HR | Sleep / HRV | Notes |
|---|---|---|---|---|
| Day 0 | Shot time, dose, site | _____ bpm | _____ | Pre-shot stress, hydration, caffeine, symptoms |
| Day 1 | First day after shot | _____ bpm | _____ | Appetite, nausea, fluids, sleep quality |
| Day 2-3 | Early-week pattern | _____ bpm | _____ | Exercise tolerance, stress, GI symptoms |
| Day 4-7 | Late-week pattern | _____ bpm | _____ | Recovery, appetite rebound, next-shot prep |
How this differs from anxiety and HRV tracking
An anxiety or HRV page is usually about symptom clusters and recovery scores. This page is narrower: it treats resting heart rate as the primary signal and asks how that number changes across baseline, first-dose weeks, titration weeks, missed-dose weeks, and stable-dose months.
- GLP-1 stress, anxiety, and HRV guide for broader nervous-system symptoms.
- GLP-1 low HRV after injection if the main wearable change is HRV, not resting heart rate.
- Semaglutide anxiety and HRV tracker or tirzepatide anxiety and HRV tracker for drug-specific tracking.
When to bring the timeline to a clinician
A log can make a medical conversation more concrete. Consider sharing your timeline if resting heart rate stays noticeably above your normal range, symptoms are getting worse, you feel palpitations or dizziness, exercise suddenly feels much harder, or the pattern started after a dose change. Do not use this page to decide on dose changes by yourself.
Track resting heart rate patterns in Jabbit
FAQ
- Can GLP-1 medications raise resting heart rate?
- Some users report higher resting heart rate or more noticeable heartbeat awareness while using GLP-1 medications. That does not prove cause. Sleep, hydration, intake, illness, caffeine, stress, and dose changes can all affect the pattern.
- How many weeks should I compare?
- When possible, compare a baseline week, the first few weeks, and at least one stable-dose week. Dose increase weeks should be labeled clearly because they are often harder to interpret.
- Should I track HRV too?
- It can help, but resting heart rate and HRV answer slightly different questions. If HRV is your main concern, use the GLP-1 low HRV page and keep this page focused on resting heart rate trends.
- Is this page a dosing guide?
- No. It is educational, harm-reduction tracking content only. Follow your medication labeling and licensed clinician guidance for treatment decisions.